Pharmaceuticals

Lab Automation In Drug Discovery Market Trends and Insights: Global Forecast to 2030

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the lab automation in drug discovery market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Lab Automation In Drug Discovery Market?

The market for lab automation in drug discovery has shown robust expansion in recent years. This market is projected to expand from $6.77 billion in 2025 to $7.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.1%. Historically, this growth has been driven by factors such as the incorporation of robotic arms in laboratory settings, a surge in pharmaceutical research and development investments, a heightened need for automation to minimize errors, the implementation of lab information management systems, and advancements in high-throughput screening technologies.

The market size for lab automation in drug discovery is projected to experience substantial growth in the upcoming years. It is forecast to expand to $8.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period can be attributed to the increasing prevalence of AI-driven drug discovery platforms, a growing demand for personalized medicine, the expansion of cloud-based lab management solutions, the integration of advanced robotics for sample handling, and a rise in collaborations between pharmaceutical and biotechnology companies. Significant trends expected during the forecast period include automated high-throughput screening, integrated laboratory workflows, the use of predictive analytics in drug discovery, the miniaturization of laboratory processes, and cloud-based lab management systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Drivers Are Supporting Technological Adoption In The Lab Automation In Drug Discovery Market?

The rising need for precision medicine is anticipated to fuel the expansion of lab automation in the drug discovery market moving forward. Precision medicine, alternatively termed personalized medicine, involves a strategy for medical treatment and prevention that considers each person’s unique variations in genes, environment, and lifestyle. Lab automation expedites research, enhances experimental consistency, and improves the effectiveness of precision medicine and drug discovery workflows, ultimately contributing to the development of more efficacious medications and diagnostics tailored to individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, announced that in 2023, the FDA granted approval to 16 new personalized treatments for patients with rare diseases, representing a substantial rise from the six approved in 2022. As a result, the escalating demand for precision medicine is propelling the growth of lab automation within the drug discovery market.

What Segment Types Are Examined In The Lab Automation In Drug Discovery Market?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Trends Are Projected To Support The Growth Of The Lab Automation In Drug Discovery Market?

Leading companies active in the drug discovery lab automation market are concentrating on integrating AI-driven and robotics-based systems to accelerate the development of formulations and enhance R&D productivity. AI-powered and robot-assisted platforms leverage smart algorithms and automated equipment to streamline operations, increase precision, and expedite workflows. As an illustration, in May 2025, Intrepid Labs, a Canada-based research facility, launched its Valiant platform, an AI-driven and robotics-enabled system engineered to dramatically speed up drug formulation development. Supported by more than $11 million in total funding, which includes a recent $7 million seed round led by AVANT BIO, the company’s objective is to substitute slow, trial-and-error formulation processes with swift, data-driven optimization. Valiant autonomously explores entire formulation design spaces, cutting timelines from months to days while simultaneously improving therapeutic performance and safety. Since its establishment in 2023, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

Who Are The Prominent Global Companies Shaping The Lab Automation In Drug Discovery Market Landscape?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lab Automation In Drug Discovery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2026, By The Business Research Company

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Lab Automation In Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report

Lab Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795